Sugi Predict

Sugi Predict / Compounds / SCHEMBL338631

SCHEMBL338631

SCHEMBL338631

NCCCCCN1C(=O)C=CC1=O

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 10/20 0.77
▸ FAAH O00519 5/20 0.77
▸ ALDH1A1 P00352 2/20 0.77
▸ LMNA P02545 2/20 0.77
▸ MAPT P10636 2/20 0.77
▸ NPSR1 Q6W5P4 2/20 0.77
▸ HSP90AA1 P07900 1/20 0.77
▸ TLR9 Q9NR96 1/20 0.77
▸ TP53 P04637 1/20 0.77
▸ PKM P14618 1/20 0.77
▸ HPGD P15428 1/20 0.77
▸ XBP1 P17861 1/20 0.77
▸ MAPK1 P28482 1/20 0.77
▸ HTT P42858 1/20 0.77
▸ RECQL P46063 1/20 0.77
▸ RAB9A P51151 1/20 0.77
▸ SMN1; SMN2 Q16637 1/20 0.77
▸ GPR35 Q9HC97 1/20 0.77
▸ GPR55 Q9Y2T6 1/20 0.77
▸ PTGS1 P23219 7/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9999878 1.00 MGLL (0.77) MGLLFAAHALDH1A1LMNAMAPT
SCHEMBL4174559 1.00 MGLL (0.77) MGLLFAAHALDH1A1LMNAMAPT
SCHEMBL25586313 1.00 MGLL (0.77) MGLLFAAHALDH1A1LMNAMAPT
SCHEMBL25586309 1.00 MGLL (0.77) MGLLFAAHALDH1A1LMNAMAPT
SCHEMBL25586311 1.00 MGLL (0.77) MGLLFAAHALDH1A1LMNAMAPT
SCHEMBL25586310 1.00 MGLL (0.77) MGLLFAAHALDH1A1LMNAMAPT
SCHEMBL25586312 1.00 MGLL (0.77) MGLLFAAHALDH1A1LMNAMAPT
Hydrochloric Acid SCHEMBL7515365 0.98 MGLL (0.74) MGLLFAAHALDH1A1LMNAMAPT
Hydrochloric Acid SCHEMBL3402339 0.98 MGLL (0.74) MGLLFAAHALDH1A1LMNAMAPT
SCHEMBL2919549 0.98 MGLL (0.76) MGLLFAAHALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 217 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119751939-A Waterproof PET film for photovoltaic backboard and preparation method thereof 浙江大东南股份有限公司 2025-04-04 — — CN claimed
WO-2024140237-A1 SOLID-STATE BATTERY CELL, AND PREPARATION METHOD AND USE 北京卫蓝新能源科技有限公司 2024-07-04 — — WO claimed
CN-115763967-A Solid-state battery cell, preparation method and application 北京卫蓝新能源科技有限公司 2023-03-07 — — CN claimed
CN-111920959-B ROS (reactive oxygen species) -responsive heparin polysaccharide nano prodrug compound based on click reaction, nano preparation, and preparation method and application thereof 中国药科大学 2022-03-25 — — CN claimed
US-10953073-B2 XTEN conjugate compositions and methods of making same AMUNIX PHARMACEUTICALS, INC. (US) 2021-03-23 — — US claimed
CN-111920959-A ROS (reactive oxygen species) -responsive heparin polysaccharide nano prodrug compound based on click reaction, nano preparation, and preparation method and application thereof 中国药科大学 2020-11-13 — — CN claimed
WO-2013130684-A1 XTEN-FOLATE CONJUGATE COMPOSITIONS AND METHODS OF MAKING SAME AMUNIX OPERATING INC. (US) 2013-09-06 — — WO claimed
CN-121586704-A Adhesive photoprotective compounds and uses thereof 斯奇诺西维 2026-02-27 — — CN disclosed
US-20250276074-A1 BRM AND BRG1 TARGETING ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF PRELUDE THERAPEUTICS INCORPORATED 2025-09-04 — — US disclosed
WO-2025106634-A1 MCL-1 INHIBITOR COMPOUNDS AND USE IN ANTIBODY DRUG CONJUGATES GENENTECH, INC. (US) 2025-05-22 — — WO disclosed
CN-119751939-A Waterproof PET film for photovoltaic backboard and preparation method thereof 浙江大东南股份有限公司 2025-04-04 — — CN disclosed
US-20250073345-A1 ANTIBODY-CONJUGATED CHEMICAL INDUCERS OF DEGRADATION AND METHODS THEREOF GENENTECH, INC. (US) 2025-03-06 — — US disclosed
EP-4469089-A1 ANTIBODY-CONJUGATED CHEMICAL INDUCERS OF DEGRADATION AND METHODS THEREOF Genentech Inc. (US) 2024-12-04 — — EP disclosed
WO-2000035948-A1 METHODS AND COMPOSITIONS FOR TREATING DISORDERS INVOLVING EXCITOTOXICITY BIOGEN, INC. (US) 2000-06-22 — — WO disclosed
EP-1009424-A2 REGULATION OF MUSCLE TISSUES BY HEDGEHOG-LIKE POLYPEPTIDES, AND FORMULATIONS AND USES RELATED THERETO Ontogeny, Inc. (US) 2000-06-21 — — EP disclosed
WO-2000027422-A2 METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING PERIPHERAL NEUROPATHIES BIOGEN, INC. (US) 2000-05-18 — — WO disclosed
WO-1999028343-A9 HYDROPHOBICALLY-MODIFIED PROTEIN COMPOSITIONS AND METHODS BIOGEN INC (US) 1999-10-14 — — WO disclosed
WO-1999028343-A2 HYDROPHOBICALLY-MODIFIED PROTEIN COMPOSITIONS AND METHODS BIOGEN, INC. (US) 1999-06-10 — — WO disclosed
WO-1999020298-A1 REGULATION OF EPITHELIAL TISSUE BY HEDGEHOG-LIKE POLYPEPTIDES, AND FORMULATIONS AND USES RELATED THERETO ONTOGENY, INC. (US) 1999-04-29 — — WO disclosed
WO-1999010004-A2 REGULATION OF MUSCLE TISSUES BY HEDGEHOG-LIKE POLYPEPTIDES, AND FORMULATIONS AND USES RELATED THERETO ONTOGENY, INC. (US) 1999-03-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250073345-A1 ANTIBODY-CONJUGATED CHEMICAL INDUCERS OF DEGRADATION AND METHODS THEREOF ADRM1, PML, ATG7 MGLL 3411/4885FAAH 2573/4885ALDH1A1 1423/4885
US-10953073-B2 XTEN conjugate compositions and methods of making same XPA, TXLNA, NGLY1 MGLL 3726/4885FAAH 3148/4885ALDH1A1 3685/4885
US-20250276074-A1 BRM AND BRG1 TARGETING ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF CRBN, RBX1, SMARCE1 MGLL 3716/4885FAAH 3480/4885ALDH1A1 1678/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.